A qualitative and quantitative evaluation of amantadine in the treatment of Parkinson's disease
- 31 March 1972
- journal article
- clinical trial
- Published by Elsevier in Journal of Chronic Diseases
- Vol. 25 (3), 149-182
- https://doi.org/10.1016/0021-9681(72)90171-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- AMANTADINE VERSUS L-DOPA AND AMANTADINE PLUS L-DOPAThe Lancet, 1970
- AMANTADINE DOSAGE IN TREATMENT OF PARKINSON'S DISEASEThe Lancet, 1970
- AMANTADINE IN PARKINSONISMThe Lancet, 1970
- CONTROLLED TRIAL OF AMANTADINE HYDROCHLORIDE IN PARKINSON'S DISEASEThe Lancet, 1970
- Amantadine in the Treatment of Parkinson's DiseaseJAMA, 1969
- ParkinsonismNeurology, 1967
- Trial of amantadine in epidemic influenzaClinical Pharmacology & Therapeutics, 1966
- QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL*Annals of the New York Academy of Sciences, 1965
- COGNITIVE FUNCTION IN PARKINSONʼS DISEASE1Journal of Nervous & Mental Disease, 1962
- A METHOD FOR EVALUATING DISABILITY IN PATIENTS WITH PARKINSONʼS DISEASEJournal of Nervous & Mental Disease, 1961